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ABSTRACT
The integument of the squid Dosidicus gigas is an industrial
waste and trouble the industrial processing. In this study, we
examined the lipid composition and neuroprotective effects of
D. gigas integument lipidic extract (DGI) in SH-SY5Y neuroblastoma cells which have been exposed to H2O2. The results
showed that phospholipids, triacylglycerol and cholesterol
accounted for 70.90 ± 4.96 (mean ± S.D.), 20.70 ± 3.54 and
8.40 ± 0.28% of DGI, respectively. And the main fatty acids
were docosahexaenoic acid (30.53% of total fatty acid), palmitic acid (20.36% of total fatty acid) and eicosapentaenoic
acid (11.84% of total fatty acid). DGI at the concentrations of
2, 4 and 8 mg/ml successfully protected SH-SY5Y cells against
the cytotoxicity, markedly increased the cell proliferation, antioxidant enzymes of glutathione contents and catalase activities, and inhibited the secretion of amyloid β-peptide 1-42.
Our results suggested that DGI may be a possible approach in
the prevention of Alzheimer’s disease and other neurodegenerative diseases.

I. INTRODUCTION
The first histological clinical report of Alzheimer’s disease
(AD) is mentioned in 1907 [1]. The observations of patients
with clinically developed AD indicate that numerous psychopathological symptoms, including intellectual dysfunctions,
orientation dysfunctions, memory dysfunctions, emotional
disturbances, motor and psychomotor dysfunctions, etc. [3].
These psychopathological symptoms would make AD patients
lose living abilities gradually and depend on families and
care-givers severely, and acting like a neonate. Up to 90% of
patients with dementia developed significant behavioral problems during the course of their illness [34], however the subPaper submitted 06/02/09; revised 10/28/09; accepted 02/05/10. Author for
correspondence: Pai-An Hwang (e-mail: pahwang@mail.tfrin.gov.tw).
*Seafood Technology Division, Fisheries Research Institute, Council of Agriculture, Keelung, Taiwan, R.O.C.

stantial proportion of patients with AD develop delusions or
hallucinations sometimes over the course of their illness [32].
In other words, AD is considered simply as another form of
dementia and it is common for aging individuals as well.
Amyloid β-peptide (Aβ), an insoluble fibril deposites, is the
major component of the senile plaques (SP) that characterize
AD brain [15]. It has been demonstrated that Aβ is toxic directly to cultured neuron [37], and Aβ monomers assemble
into dimmers, trimmers and higher aggregates, all of which are
highly neurotoxic associated with AD [39]. Aβ involved on
various neuronal cells surface receptors to generate reactive
oxidative species (ROS), and ROS also leads to the hyperphosphorylation of Tau protein that destabilizes microtubules.
This process eventually forms intracellular neurofibrillary
tangles, one of observable hallmark pathology of AD [45]. In
brain tissue, the level of thiobarbituric acid reactive substances
(TBARS), superoxide dismutase (SOD) activity and catalase
(CAT) activity are significantly decreased in AD temporal
cortex when compared to age-matched controls [26]. It was
observed that the sites of neurodegeneration and oxidative
stress are associated with increased Aβ deposits in AD brain
[19]. According to these observations, it is directly responsible for oxidative damage to neuron, leading to subsequent neuronal loss in the AD brain.
The squid Dosidicus gigas, also known as jumbo flying
squid, is a commonly used by frozen seafood processing companies. Fresh squid D. gigas has a sticky consistency and their
tissue is chewy. Its integument is separated from the edible
part when unfrozen by hot water and treated as a fishery
wastes troubling industrial processing [31]. Reportedly the
phospholipids is 80-85% of total lipid in squid Ommastrephes
bartrami, and docosahexaenoic acid (DHA) is a major fatty
acid of total compositional fatty acid, moreover eicosapentaenoic acid (EPA) as the second [33, 10]. Numerous studies
have reported that dietary DHA is required during development when cellular differentiation [7], enhanced a maze-learning ability in aged mice [24], prevention of AD [8], and reduced fish or DHA intake increases risk for AD [25]. Besides,
phospholipids is a potentially useful source of ω-3 polyunsaturated fatty acid, and it has showed that intestinal absorption of phospholipids is followed by preferential uptake of ω-3
polyunsaturated fatty acid by the brain [27]. In animal model,
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it was also proved that DHA-enriched phospholipid diets
supplement could restore DHA levels and cholinergic activity and modulate age-related alterations in hippocampus
[14]. However, the action of lipidic extract from squid is still
unclear, even though it is rich in ω-3 fatty acid.
In this study, we are the first one to investigate the neuroprotective effect of D. gigas integument lipidic extract (DGI)
in SH-SY5Y neuroblastoma cells which have been exposed to
H2O2. To determine if integument of D. gigas could be a new
resource of ω-3 fatty acid enriched phospholipids, which could
be prepared to a reasonable cost.

II. MATERIALS AND METHODS
1. Material and Reagent
The integument of D. gigas was kindly supplied by the
Mei-er Hau Fishing Co., Ltd (Tainan, Taiwan) as refrigerated
lumps. SH-SY5Y, the neuroblastoma cell line was obtained
from the Culture Collection and Research Center (CCRC,
Hsinchu, Taiwan), originally from the American Type Culture
Collection. All other reagents used in this study were of
chemical grade and commercially available.
2. Extraction of D. gigas Integument Lipidic Extract
(DGI)
The refrigerated integument was thawed, weighed, chopped
and then stirred with ten volumes of acetone for 4 hr, and
filtered through a filter paper (No. 1 TOYO, Japan). After
filtering, the residual integument was dried in the dryer with
current air (RISEN Co., LTD, RHD-602D) at 35°C for 2 hr,
and then the residual integument was extracted with ten
volumes of ethanol for 12 hr and centrifuged (2,000 × g, 20
min). The supernatants were combined, concentrated under
reduced pressure at 45°C, and DGI was obtained, and then
kept it at -20°C for the following tests.
3. Lipid and Fatty Acid Composition Analyses of DGI
Qualitative and quantitative analyses of the lipid composition present in the integument extract were performed by thinlayer chromatography (TLC) coupled to an automated flame
ionization detector (FID) system (Iatroscan MK-5, Iatron
Laboratories, Tokyo, Japan). Triacylglycerol (TG), cholesterol, phosphatidylethanolamine (PE), phosphatidylcholine
(PC) and phosphatidylserine (PS) standards were purchased
from Sigma Chemical Co. The standards and DGI were dissolved in chloroform/methanol (2:1, v/v). The samples (1.0 µl)
were spotted onto silica gel-coated Chromarods (type S-III)
(Iatron Laboratories) by procedure of a 2 µl syringe Hamilton
(Bondaluz, Switzerland) coupled to an SES 3202/IS-02 semiautomatic sample spotter (Nieder-Olm, Germany). The rods
were developed consecutively four times using the following
mobile phase: (1) 60 ml of chloroform/methanol/water/25%
NH3 (47:20:2.5:0.28, v/v/v/v) up to 1 cm; (2) 60 ml of hexane/
diethyl ether (63:7, v/v) up to 9 cm; (3) 70 ml of hexane/

benzene (35:35, v/v) up to 10 cm. After each development the
rods were heated for 10-12 min at 60°C to dry the remaining
solvent, and run through a flame ionization detector in the
Iatroscan by using an air flow of 2.0 l/min atmospheric air, a
hydrogen flow of 150 ml/min (high purity hydrogen, C50) and
a scanning speed of 3.0 s/cm. A total scan was performed to
identify all the lipid components. Data were processed with
the Boreal software version 2.5. All data were analyzed in
triplicate. The method was modified by Dominguez et al.
[12].
DGI was prepared for fatty acid analysis according to the
AOAC (FAME method) standard [16] and analyzed by capillary GC-FID (HP 5890 series II, HP-Innowax cross-linked
PEG column). GC conditions were as follows: injector 250°C,
detector 300°C, oven 210°C, and carrier-nitrogen 1 ml/min.
The individual fatty acid peaks in the chromatograms were
identified by comparison with authentic standards (Sigma
Chem. Co.).
4. Cell Culture
SH-SY5Y neuroblastoma cells were grown in complete
minimum essential medium (MEM) in a humidified air/5%
CO2 chamber at 37°C. Sixteen hours prior to treatment cells
were washed free of fetal calf serum (FCS) containing medium and further incubated in FCS-free MEM containing
SH-SY5Y cells growth supplement N2. All cell culture materials were purchased from Gibco Life Technologies (Rockville,
MD, USA).
SH-SY5Y cells (2 × 105) were treated with 50 µM H2O2 for
30 sec, and then treated with or without different concentrations of DGI (2, 4, 8 mg/ml) dissolved in 0.4% dimethyl sulfoxide (DMSO) in MEM for 24 hr. Cells treated without H2O2
and DGI as negative control (NC) and cells treated with H2O2
alone as positive control (PC). The concentration of H2O2 (50
µM) was the result of previously study which demonstrated
ability to induce oxidative stress cell cytotoxicity and Aβ
secretion [28].
5. Cell Proliferation Assay
Proliferation of cells was determined by streptomycin, 3-(4,
5-dimethyl thiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) colorimetric assay [38]. SH-SY5Y cells were washed
with PBS three times and MTT (1 mg/ml) was added to the
medium for 4 hr, and OD was read at 570 nm in an enzymelinked immunosorbent assay (ELISA) reader (Molecular Devices, Wako, Tokyo) [29]. The relative cell proliferation % =
(A1/A0) × 100%, A0 was the absorbance of NC, and A1 were
the absorbance of DGI (0, 2, 4, 8 mg/ml) treated with H2O2.
The relative cell proliferation of NC was regarded as 100%.
6. Enzyme Activities Assay
For evaluating the content of glutathione (GSH) and CAT
activity, SH-SY5Y cells (2 × 105) were treated with 50 µM
H2O2 for 30 sec, and then treated with or without different
concentrations of DGI (2, 4, 8 mg/ml) dissolved in 0.4%
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Table 1. Lipid composition of D. gigas integument lipidic
extract (DGI).

Table 2. Fatty acid composition of total fatty acid in D.
gigas integument lipidic extract (DGI)

Composition

Content* (%)

Fatty acid

Triacylglycerol (TG)

20.70 ± 3.54

C14:0

1.93

8.40 ± 0.28

C16:0

20.36

70.90 ± 4.96

C17:0

2.08

C18:0

10.69

Cholesterol
Total phospholipids
Phospholipids classes

Area% of gas chromatography

Phosphatidylcholine (PC)

44.52 ± 5.23

C18:1 (ω-9)

2.83

Phosphatidylethanolamine (PE)

22.58 ± 0.45

C18:3 (ω-3)

8.05

6.80 ± 2.35

C20:4 (ω-6)

4.66

26.10 ± 1.69

C20:5 (ω-3)

11.84

Phosphatidylserine (PS)
Others
*Mean ± SD, n = 3

DMSO in MEM for 24 hr. Cellular GSH and CAT were determined using commercial assay kit (Cayman, Catalog No.
703002 and 707002), and OD was read at 405 and 540 nm in
an ELISA reader. All assays were performed in triplicate.
7. Amyloid β-peptide (Aβ) assay
Aβ 1-42 secretion was determined by a sandwich ELISA kit
(Covance, Catalog No. SIG-38942). SH-SY5Y cells (2 × 105)
were treated with 50 µM H2O2 for 30 sec, and then treated with
or without different concentrations of DGI (2, 4, 8 mg/ml) dissolved in 0.4% DMSO in MEM for 24 hr. After incubation, cell
culture medium was removed after desired time and assayed
for Aβ. The Aβ ELISA assay was performed in triplicate.
8. Statistical Analysis
The data presented are mean ± S.D. of three determinations,
and differences were considered to be statistically significant
if P < 0.05.

III. RESULT AND DISSCUSSION
1. Lipid Composition of DGI
The integument of D. gigas was tough but not fibrous. The
content of DGI on dry base was 5.10%, since 550.8 mg of DGI
was obtained from 10.8 g of dry D. gigas integument. Separation of lipid and phospholipids classes in DGI was accomplished by TLC-FID using Iatroscan technique, which was
sensitive and quantitative for each lipid composition [11]. The
lipid composition of DGI is given in Table 1. Phospholipids
accounted for 70.90 ± 4.96% of DGI, which was lower than
the phospholipids content of total lipid in integument of squid
Ommastrephes bartrami (80-85% of total lipid) [10]. The TG
and cholesterol of DGI were 20.70 ± 3.54 and 8.40 ± 0.28%,
respectively, which were lower than phospholipids content
(Table 1). It was also known that total lipid extracted from the
mantle of female squid Illex argentines had a higher percentage of phospholipids and had lower sterols [30]. But the liver
lipid of squid Watasenia scuntillans had high level of TG
(60.9-72.7%) [22].

C22:1

2.05

C22:5 (ω-3)

0.56

C22:6 (ω-3)

30.53

Others

4.42

The major component of phospholipids in DGI was PC
(44.52 ± 5.23% of total phospholipids), PE (22.58 ± 0.45% of
total phospholipids) and PS (6.80 ± 2.35% of total phospholipids) as follow. Our result was similar to the component of
phospholipids in squid O. bartrami [10]. PC was found to be
the main composition in the phospholipids classes of squid,
such as Sthenoteuthis oualaniensis egg (67.50% of total
phospholipids) [40], Loligo vulgaris (56% of total phospholipids) [23], and squid eye (30.7% of total phospholipids) [43].
Generally marine oils were vulnerable to oxidation, but in
comparative study on oxidative stability indicated that PC of
squid eye was oxidatively more stable than PC of soybean in
liposomes [43]. Besides, in oxidative stability of lipid containing phospholipids did not always decrease with increasing
phospholipids contents, and stability was strongly influenced
by phospholipids composition [6]. So, it was suggested that
DGI may be an oxidatively stable lipidic extract of D. gigas
integument.
2. Fatty Acid Compositions of DGI
The composition in terms of the important fatty acid of total
fatty acid in DGI was shown in Table 2. The main fatty acids
in DGI were DHA (C22:6 ω-3) (30.53% of total fatty acid),
palmitic acid (C16:0) (20.36% of total fatty acid) and EPA
(C20:5 ω-3) (11.84% of total fatty acid). Comprising fatty
acid composition of integument of O. bartrami, the main fatty
acids were also DHA (34.4% of total fatty acid), palmitic acid
(29.8% of total fatty acid) and EPA (14.1% of total fatty acid)
[10]. Since phospholipids were a major composition of DGI,
and total phospholipids were rich in DHA and EPA. Results
implied that DGI was could be utilized as a good source of ω-3
rich phospholipids.
3. Effects of DGI on Cell Proliferation
H2O2 (50 µM), a known oxidative stress inducer, which
resulted in significant induction of cell cytotoxicity shown by
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loss of cell viability, so we then tested whether DGI protected
SH-SY5Y cells against H2O2-induced cell death. As determined by MTT colorimetric assay, oxidative stress by H2O2
resulted in a decrease of the relative cell proliferation by
52.74 ± 2.82% (Fig. 1). DGI significantly inhibited cell death
induced by H2O2, resulting in an increase in the relative cell
proliferation of 99.57 ± 8.29%, 98.95 ± 9.67% and 90.11 ±
5.42% at concentrations of 2, 4 and 8 mg/ml, respectively (Fig.
1). Calvert et al. [5] demonstrated that post-treatment of DHA
could protect SH-SY5Y cells from glutamate-induced cell
death, and DHA showed significant and dose-dependent increases in the percentage of cells with longer neurites [41, 42].
Therefore, it was suggested that DGI had inhibitory effect
against oxidative stress as a result of rich in ω-3 fatty acid.
4. Effect of DGI on Antioxidant Activities
It has been known that antioxidant system protects cells
from H2O2, oxygen free radicals, etc. This system consisted of
the enzymes GSH, CAT and SOD [13]. A decrease in the
activity of any of these enzymes would most likely lead to cell
death in brain [35], and AD brain is subjected to increased
oxidative stress resulting from reactive oxygen species [36].
In recently clinical trials, DHA enriched phospholipids were
used as neuroprotective substance [9] and ω-3 fatty acid could
prevent from Alzheimer’s disease in animal model [8]. In an
attempt to discern where DGI acted as oxidative protecting
substance, we analyzed the content of GSH and the activity of
CAT in follow.
The content of GSH and the activity of CAT from SHSY5Y
cells were determined using ELISA kit. The content of GSH
from negative control was 3.70 ± 0.22 mol/g protein and was
markedly decreased by H2O2 in positive control to a level of
2.05 ± 0.09 mol/g protein. When DGI was added, it improved
significantly the content of GSH, resulting in an increase of

PC

2

DGI (mg/ml)
Fig. 2. Effect of D. gigas integument lipidic extract (DGI) on the glutathione (GSH) content by H2O2-induced SH-SY5Y cells (n = 3).
Means with asterisk were significantly different from the positive
control (P < 0.05).

4
*

CAT activity (μmol/min/mg protein)

Fig. 1. Effect of D. gigas integument lipidic extract (DGI) on the relative
cell proliferation by H2O2-induced SH-SY5Y cells (n = 3). Means
with asterisk were significantly different from the positive control
(P < 0.05).

NC

*

*

4

8

3

2

1

0

NC

PC

2

DGI (mg/ml)
Fig. 3. Effect of D. gigas integument lipidic extract (DGI) on the catalase
(CAT) activity by H2O2-induced SH-SY5Y cells (n = 3). Means
with asterisk were significantly different from the positive control
(P < 0.05).

3.10 ± 0.20, 3.85 ± 0.17 and 3.84 ± 0.15 mol/g protein at
concentrations of 2, 4 and 8 mg/ml respectively, and the value
was closer to negative control (Fig. 2). Similarly, cellular CAT
activity was decrease by H2O2 from 3.5 ± 0.14 to 2.3 ± 0.08
µmol/min/mg protein (Fig. 3). After DGI was adding, the
CAT activities improved in an increase of 3.24 ± 0.16, 3.37 ±
0.09 and 3.26 ± 0.20 µmol/min/mg protein at concentration of
2, 4 and 8 mg/ml respectively (Fig. 3). It was showed that DGI
protected against H2O2 induced GSH and CAT loss.
Recently Kaur et al. [21] have shown that DHA acted as a
neuroprotector for methylmercury-induced neurotoxicity in
primary neural cell, and DHA also successfully protected
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neurons against the glutamate-induced cytotoxicity, markedly
increased the cell viability and the activities of glutathione
peroxidase and glutathione reductase [40]. So we considered
that DGI was rich in DHA, thereby DGI may be a neuroprotector for H2O2-induced neurotoxicity in neural cell.
5. Effect of DGI on Aβ 1-42 secretion
Aβ 1-42, Aβ 1-40 and Aβ 25-35 were all toxic to cultured
hippocampal neurons [44], subsequent study showed that Aβ
1-42 implicated for neurodegeneration in AD brain [4]. In
order to analyze the potential anti-Aβ-induced neurotoxicity
properties of DGI, we analyzed the level of cellular Aβ 1-42.
Aβ 1-42 secretion from SH-SY5Y cells was 6.63 ± 1.07 pg/mg
in negative control, and was markedly stimulated by H2O2
to 42.30 ± 3.65 pg/mg. When DGI was added, it decreased
significantly the level of Aβ 1-42, resulting in a decrease of
8.30 ± 1.55, 9.07 ± 2.87 and 8.73 ± 3.61 pg/mg protein at
concentrations of 2, 4 and 8 mg/ml respectively, and the values
were significantly lower than positive control (Fig. 4). In
addition, enrichment of culture media with DHA has been
found to reduce the level of Aβ in PC12 neuron cells [20], and
DHA also could significantly decreased the level of Aβ in AD
rats [18]. EPA, another important ω-3 fatty acid, acted as a
precursor for DHA, which could ameliorate learning deficits
associated with AD [17]. But, a contrary opinion was reported
that DHA and EPA may accelerate neuronal loss in the terminal stages of prion or AD [2].
In conclusion, our study demonstrated the fact that DGI at
physiological concentrations was able to protect neuronal cells
from H2O2-induced cell cytotoxicity, oxidative stress and Aβ
secretion for the first time. These findings were significant
demonstrated that DGI may be a possible approach in the
prevention of AD and other neurodegenerative diseases.
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